| CSRIX | TIRHX | CSRIX / TIRHX | |
| Total Expense Ratio | 0.75 | 0.62 | 121% |
| Annual Report Gross Expense Ratio | 0.76 | 0.62 | 123% |
| Fund Existence | 26 years | 10 years | - |
| Gain YTD | 2.589 | 1.634 | 158% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 100000 | 1,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 7.9B | 2.55B | 309% |
| Annual Yield % from dividends | 3.14 | 3.43 | 92% |
| Returns for 1 year | 7.31 | 5.52 | 133% |
| Returns for 3 years | 18.95 | 15.06 | 126% |
| Returns for 5 years | 31.58 | 16.60 | 190% |
| Returns for 10 years | 51.05 | 60.38 | 85% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| NQGCX | 44.03 | 0.12 | +0.27% |
| Nuveen Global Equity Income C | |||
| ASCLX | 12.26 | -0.03 | -0.24% |
| AB Select US Long/Short C | |||
| VRTTX | 591.12 | -2.60 | -0.44% |
| Vanguard Russell 3000 Index I | |||
| IGSLX | 11.99 | -0.14 | -1.15% |
| Impax Global Social Leaders Investor | |||
| BRWRX | 25.58 | -0.34 | -1.31% |
| MFS Blended Research Growth Eq R1 | |||